Made
possible by charitable contributions from
Genentech
and
Accuray Cyberknife.
Click to Zoom
Our monthly newsletter, the HotSheet, highlights the latest in treatment strategies as well as emerging treatments. The HotSheet is distributed
free at chapter support group meetings, and is available in PDF on the Us TOO web site.
HotSheet Personal Subscriptions Now Available
If you are unable to attend chapter meetings to get the latest issue or prefer an original copy, we can deliver the newsletter right to your home or office.
Download and print a subscription order form
or order online .
January - March |
April - June | July - September | October - December
January View Newsletter
February View Newsletter
March View Newsletter
Includes:
Us TOO Board Leadership Changes
MRI Can Identify Metastatic Lymph Nodes
Treatment Found for Lethal Prostate Cancer
Index of Articles in the 2011 HotSheets
2011 Prostate Cancer Business Leadership Council Members & Supporters Recognized
Doc Moyad’s “No Bogus Science” Column – “Another Reason to Donate to Us TOO”
Characteristics & Outcomes of Prostate Cancers Diagnosed by 21-Core Biopsies
Revlimid® Fails to Help Prostate Cancer
Ask Doctor Snuffy Myers
MRI Highly Accurate in Guiding Biopsies
Read
more..
Includes:
Outercourse Vs. Intercourse Revisited
Statins & Risk of Fatal Prostate Cancer
‘Amazing’ Prostate Cancer Marker (EPCA-2) Paper Now Retracted
MRI-Guided Prostate Biopsies in Men with Increased PSA & Prior Negative Biopsies
Docetaxel with/without Estramustine
Ask Doctor Snuffy Myers
Proton Therapy Effective for Prostate Cancer
Recent Additions to the Us TOO Website
Robot prostatectomy vs. standard surgery
Hormone Therapy Tied to Blot Clots
New Content on My Prostate Cancer Roadmap
Doc Moyad’s “No Bogus Science” Column – “Statins & Risk of Fatal Prostate Cancer”
Doctor Chodak’s Bottom Line
Prostate RT and Risk of Rectal Cancer
Read
more..
Includes:
MDV3100 in Prostate Cancer “Impressive”
Bone Metastases Target of New Agent
Benefits of Xgeva Don’t Outweigh Risks
Medicare Will Continue Covering PSA Screening
Finasteride Combo Reduces Recurring PSA
Doc Moyad’s “No Bogus Science” Column – “Low-fat milk & Prostate Cancer Progression?”
EBRT More Costly and Toxic than Other RT
Us TOO Advocacy Issues Column
Save the Dates for September Prostate Cancer Awareness Month
Inherited Prostate Cancer Gene Identified
Exercise Reduces Prostate Cancer Recurrence?
Read
more..
April View Newsletter
May View Newsletter
June View Newsletter
Includes:
FDA Approves PCA3 Urine Test
RP Improves Survival of PSA-Detected Cancer
Men Opting for Costly New Cancer Treatment
Robotic Vs. Open Radical Prostatectomy
Finasteride and Dutasteride Do Not Control Low-Risk Prostate Cancer
Result of the REDEEM Study of Dutasteride
Us TOO Advocacy Issues
Reduced Incidence of Post-Prostate Biopsy Infections by Using Rectal Swab Cultures
Phase 3 Randomized Trial of Ipilimumab
Ask Doctor Snuffy Myers
Doc Moyad’s “No Bogus Science” Column – “Is it Time for Me to Start Drinking Coffee?”
Doctor Chodak’s Bottom Line
Read
more..
Includes:
Clinical Trials Deliver on the Promise of Science
Early Access for MDV3100 and Alpharadin
Serial Prostate Biopsies & Insignificant Cancers
Prostate Cancer Misclassification by Current Low-Risk & Active Surveillance Criteria
Association Between Smoking & PSA Levels
Galeterone Safe & Effective in Prostate Cancer
Oxygen in Tumors & Response to Radiotherapy
Endorectal MRI & Active Surveillance
Ask Doctor Snuffy Myers
High-Dose Image Guided Radiotherapy Com-pared to IMRT for Localized Prostate Cancer
Doc Moyad’s “No Bogus Science” Column – “The secret to long life is following 6-7 things”
Gene Mapping Not a Crystal Ball if Healthy
Doctor Chodak’s Bottom Line
Read
more..
